FRAX and its applications to clinical practice
- PMID: 19195497
- DOI: 10.1016/j.bone.2009.01.373
FRAX and its applications to clinical practice
Abstract
The introduction of the WHO FRAX algorithms has facilitated the assessment of fracture risk on the basis of fracture probability. FRAX integrates the influence of several well validated risk factors for fracture with or without the use of BMD. Its use in fracture risk prediction poses challenges for patient assessment, the development of practice guidelines, the evaluation of drug efficacy and reimbursement, as well as for health economics which are the topics outlined in this review.
Similar articles
-
Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.Bone. 2009 Jun;44(6):1049-54. doi: 10.1016/j.bone.2009.02.014. Epub 2009 Feb 28. Bone. 2009. PMID: 19254788 Clinical Trial.
-
Assessment of fracture risk.Eur J Radiol. 2009 Sep;71(3):392-7. doi: 10.1016/j.ejrad.2008.04.061. Epub 2009 Aug 28. Eur J Radiol. 2009. PMID: 19716672 Review.
-
Evaluation of bone mechanical strenght and fracture risk assessment (Frax) in patients with hip joint replacement surgery.Acta Reumatol Port. 2009 Jul-Sep;34(3):504-10. Acta Reumatol Port. 2009. PMID: 19830928
-
Clinical assessment of fracture risk and novel therapeutic strategies to combat osteoporosis.Fertil Steril. 2009 Aug;92(2):403-12. doi: 10.1016/j.fertnstert.2009.05.049. Epub 2009 Jun 25. Fertil Steril. 2009. PMID: 19559412 Review.
-
Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.Am J Prev Med. 2009 Apr;36(4):366-75. doi: 10.1016/j.amepre.2009.01.013. Am J Prev Med. 2009. PMID: 19285200 Review.
Cited by
-
Impact of patient education by nurse case managers on decision making for out-of-pocket anti-osteoporotic pharmaceutical therapy: a single-center retrospective study.BMC Nurs. 2024 Nov 6;23(1):808. doi: 10.1186/s12912-024-02467-x. BMC Nurs. 2024. PMID: 39506740 Free PMC article.
-
Delineating the relationship between circulating osteoprotegerin and bone health in women with a pathogenic variant in BRCA1: A cross-sectional analysis.Bone Rep. 2024 Sep 6;22:101802. doi: 10.1016/j.bonr.2024.101802. eCollection 2024 Sep. Bone Rep. 2024. PMID: 39297019 Free PMC article.
-
Long-Term Bone Density Changes and Fracture Risk in Myasthenia Gravis: Implications for FRAX® Tool Application.Healthcare (Basel). 2024 Sep 8;12(17):1793. doi: 10.3390/healthcare12171793. Healthcare (Basel). 2024. PMID: 39273817 Free PMC article.
-
Treatment reclassification in Canada from the Osteoporosis Canada 2023 clinical practice guidelines: the Manitoba BMD Registry.Arch Osteoporos. 2024 Sep 7;19(1):86. doi: 10.1007/s11657-024-01445-9. Arch Osteoporos. 2024. PMID: 39244521
-
Short-term risk of fracture is increased by deficits in cortical and trabecular bone microarchitecture independent of DXA BMD and FRAX: Bone Microarchitecture International Consortium (BoMIC) prospective cohorts.J Bone Miner Res. 2024 Oct 29;39(11):1574-1583. doi: 10.1093/jbmr/zjae143. J Bone Miner Res. 2024. PMID: 39236248
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
